Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-29

Clinical Trial Update: Effect of Lactobacillus Plantarum 299v on Symptoms of Irritable Bowel Syndrome [Phase 4]

View source ↗

Summary

A Phase 4 trial evaluated the probiotic Lactobacillus plantarum 299v for irritable bowel syndrome and results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Lactobacillus plantarum 299V (Lactobacillus plantarum 299V)

Snippet

Sponsor: University of Stellenbosch | Conditions: Irritable Bowel Syndrome | Phase 4 | Status: COMPLETED | Results posted: 2014-09-29